The official launch of the Center for Treatment, Research and Education in Addictive Disorders (CeTREAD) was a festive occasion at the CARE/Crawley Building, bringing together diverse elements of the Greater Cincinnati addiction sciences and treatment community.
The event was a physical illustration of the CeTREAD concept, which brings together a multidisciplinary consortium of clinicians, researchers and educators dedicated to the prevention and treatment of substance use disorders. With the Dec. 9 launch, CeTREAD is now officially operating as a center of excellence within the department of psychiatry and behavioral neuroscience.
"This is indeed what differentiates us from our competitors and what will ultimately assure that we remain among the nation’s very best,” said Santa Ono, PhD, UC’s senior vice president for academic affairs and provost, said at the launch event, referring to the high degree of collaboration.
Andrew Filak, MD, interm dean of the College of Medicine and vice president for health affairs, also embraced the CeTREAD concept and welcomed the audience that included representatives from 10 different community partners.
CeTREAD includes faculty from the department of psychiatry and behavioral neuroscience, along with the department of psychology, College of Pharmacy, College of Nursing, College of Education, Criminal Justice and Human Services, the Cincinnati VA Medical Center, Cincinnati Children’s Hospital Medical Center and several community-based treatment programs.
CeTREAD’s director is Robert Anthenelli, MD, a professor in the department of psychiatry and behavioral neuroscience and director of the Tri-State Tobacco and Alcohol Research Center (Tri-TARC). Stephen Strakowski, MD, the Dr. Stanley M. and Mickey Kaplan Endowed Chair in Psychiatry, is president of the Advisory Board, which includes membership from all participating entities. A part-time director of operations will be hired.
"We really are trying to reach out from beyond the silos and walls of our own department into the rest of the academic community,” Strakowski told about 150 people gathered for the launch event.
"Of the 10 leading causes of disability worldwide, five of them are mental illness and addiction,” he added. "So we have a responsibility to address these issues in a comprehensive way.”
CeTREAD’s goal, Anthenelli says, is to establish itself through the synergy of its multidisciplinary programs as a national and international leader in addictions health care, research and education. The foundation is largely in place, he points out.
"A critical mass of clinicians, researchers and educators work together under the auspices of the department of psychiatry and behavioral neuroscience’s addiction sciences division,” he says. "Nationally recognized clinical centers of excellence in substance abuse treatment already exist at the Cincinnati Veterans Affairs Medical Center, federally funded clinical research centers are in place and training programs for many categories of allied health care professionals are established.
"All that remains to be done to compete at the highest level for further national and international recognition is to provide is to provide institutional support and resolve to promote and invest in this critically important area.”